<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="5512">
  <stage>Registered</stage>
  <submitdate>19/08/2008</submitdate>
  <approvaldate>19/08/2008</approvaldate>
  <nctid>NCT00739011</nctid>
  <trial_identification>
    <studytitle>Validation of HC250 and HC240 Series.</studytitle>
    <scientifictitle>Validation of Customer Requirements for the HC244/HC254</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>FPHC240/250Val</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive Sleep Apnea (OSA)</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - SleepStyle 254/244 CPAP series CPAP humidifier

Experimental: 1 - 


Treatment: devices: SleepStyle 254/244 CPAP series CPAP humidifier
Therapeutic CPAP pressure will be determined for individual subjects during the titration portion of an overnight sleep study. This pressure will range from 4 to 20 cmH20

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Apnea Hypopnea Index (AHI)</outcome>
      <timepoint>At the end of the sleep study</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusions criteria:

          -  AHI &gt; 15 on the diagnostic night or portion of the split night study.

          -  =18yrs of age</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Exclusion criteria:

          -  Significant Central Apnea

          -  CHF

          -  Co-existing obesity related hypoventilation

          -  Inability to give informed consent

          -  Patient intolerance to CPAP

          -  Anatomical or physiological conditions making CPAP therapy inappropriate.

          -  Less than 3 hours in the titration period

          -  Under Land Transport New Zealand (LTNZ) investigation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/08/2008</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/11/2008</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Auckland</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Fisher and Paykel Healthcare</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is designed to determine the effectiveness of two different CPAP devices. One a
      standard CPAP which has the ability to store comprehensive compliance and efficacy data and
      the second a auto adjusting CPAP which uses the energy spectrum analysis of flow signals to
      automatically adjust CPAP pressure and improve sleep variables.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00739011</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jessica Hayward, MSc</name>
      <address>Fisher and Paykel Healthcare</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>